# US 2024/0266008 A1 · Systems and Methods for Designing Augmented Randomized Trials

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0266008 A1
- Document ID: US20240266008A1
- Status: Published application
- Kind: A1
- Application number: 18/163,157
- Filed: 2023-02-01
- Published: 2024-08-08
- Earliest claimed: 2023-02-01
- Assignees: Unlearn.AI, Inc.
- Applicants: Unlearn.AI, Inc.
- Inventors: David Putnam Miller; Jonathan Ryan Walsh
- Web page: https://patentgrep.com/patent/US20240266008A1

## CPC

- G16H 10/20: for electronic clinical trials or questionnaires
- A61B 5/4848: {Monitoring or testing the effects of treatment, e.g. of medication}
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Systems and methods for designing random control trials in accordance with embodiments of the invention are illustrated. One embodiment includes a method for designing a target random control trial. The method includes steps for generating a set of prognostic scores for a set of samples. The set of prognostic scores includes prognostic scores at each of several points in time for each sample. The method includes assessing discrimination and bias metrics for the set of generative models based on a set of outcomes for the set of samples that includes outcomes at each of several points in time for each sample. The method includes determining a set of target trial parameters for a randomized control trial (RCT) based on the assessed discrimination and bias metrics, generating result data using the set of generative models, and determining treatment effects for the RCT using the generated result data.

## Claims

### Claim 1

A method for designing a target random control trial, the method comprising:
generating a set of prognostic scores for a set of samples, wherein the set of prognostic scores comprises prognostic scores at each of a plurality of points in time for each sample of the set of samples;
assessing metrics for a set of generative models based on a set of outcomes for the set of samples;
determining a set of target trial parameters for a randomized control trial (RCT) based on the assessed metrics;
generating result data using the set of generative models; and
determining treatment effects for the RCT using the generated result data.

### Claim 2 (depends on 1)

The method of claim 1, wherein the set of prognostic scores are generated based on subjects from a control arm of another trial.

### Claim 3 (depends on 1)

The method of claim 1, wherein assessing the metrics comprise a correlation.

### Claim 4 (depends on 1)

The method of claim 1, wherein the result data comprises panel data from subjects of the RCT and the generated result data comprises predicted panel data for a set of one or more digital subjects, wherein the panel data describes the observed values of multiple characteristics at multiple discrete timepoints.

### Claim 5 (depends on 4)

The method of claim 4, wherein:
the predicted panel data for the set of digital subjects is generated based on population statistics of the RCT; and
the generated result data is used to supplement control arm data of the RCT data.

### Claim 6 (depends on 4)

The method of claim 4, wherein the predicted panel data for the set of digital subjects is generated based on individual characteristics of the subjects of the RCT.

### Claim 7 (depends on 6)

The method of claim 6, wherein determining the treatment effects comprises comparing the predicted panel data based on characteristics of a particular subject with the panel data for the particular subject from the RCT data.

### Claim 8 (depends on 1)

The method of claim 1, wherein determining the set of target trial parameters comprises minimizing a total number of samples for the target random control trial.

### Claim 9 (depends on 1)

The method of claim 1, wherein determining the set of target trial parameters comprises minimizing a number of samples for the control arm of the target random control trial.

### Claim 10 (depends on 1)

The method of claim 1, wherein determining the set of target trial parameters comprises minimizing a number of samples for the treatment arm of the target random control trial.

### Claim 11

A non-transitory machine readable medium containing processor instructions for designing a target random control trial, where execution of the instructions by a processor causes the processor to perform a process that comprises:
generating a set of prognostic scores for a set of samples, wherein the set of prognostic scores comprises prognostic scores at each of a plurality of points in time for each sample of the set of samples;
assessing metrics for a set of generative models based on a set of outcomes for the set of samples;
determining a set of target trial parameters for a randomized control trial (RCT) based on the assessed bias metrics;
generating result data using the set of generative models; and
determining treatment effects for the RCT using the generated result data.

### Claim 12 (depends on 11)

The non-transitory machine readable medium of claim 11, wherein the set of prognostic scores are generated based on subjects from a control arm of another trial.

### Claim 13 (depends on 11)

The non-transitory machine readable medium of claim 11, wherein assessing the metrics comprise a correlation.

### Claim 14 (depends on 11)

The non-transitory machine readable medium of claim 11, wherein the result data comprises panel data from subjects of the RCT and the generated result data comprises predicted panel data for a set of one or more digital subjects, wherein the panel data describes the observed values of multiple characteristics at multiple discrete timepoints.

### Claim 15 (depends on 14)

The non-transitory machine readable medium of claim 14, wherein:
the predicted panel data for the set of digital subjects is generated based on population statistics of the RCT; and
the generated result data is used to supplement control arm data of the RCT data.

### Claim 16 (depends on 14)

The non-transitory machine readable medium of claim 14, wherein the predicted panel data for the set of digital subjects is generated based on individual characteristics of the subjects of the RCT.

### Claim 17 (depends on 16)

The non-transitory machine readable medium of claim 16, wherein determining the treatment effects comprises comparing the predicted panel data based on characteristics of a particular subject with the panel data for the particular subject from the RCT data.

### Claim 18 (depends on 11)

The non-transitory machine readable medium of claim 11, wherein determining the set of target trial parameters comprises minimizing a total number of samples for the target random control trial.

### Claim 19 (depends on 11)

The non-transitory machine readable medium of claim 11, wherein determining the set of target trial parameters comprises minimizing a number of samples for the control arm of the target random control trial.

### Claim 20 (depends on 11)

The non-transitory machine readable medium of claim 11, wherein determining the set of target trial parameters comprises minimizing a number of samples for the treatment arm of the target random control trial.
